Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 620.65
+6.80 (1.11%)
At close: Jul 7, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.43 billion as of July 7, 2026. Its market cap has increased by 7.56% in one year.
Market Cap
12.43B
Enterprise Value
10.06B
Revenue
6.71B
Ranking
n/a
PE Ratio
14.14
Stock Price
620.65
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.43B, an increase of 8,849.62%. That is a compound annual growth rate of 22.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 12.43B | 28.45% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 15.36B |
| Shukra Pharmaceuticals | 14.53B |
| Fredun Pharmaceuticals | 13.99B |
| Syncom Formulations (India) | 13.05B |
| TTK Healthcare | 13.02B |
| Fermenta Biotech | 10.87B |
| Wanbury | 9.92B |
| Bharat Parenterals | 9.57B |